Lenalidomide Capsule
Product Images NDC 70710-1031

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lenalidomide (NDC 70710-1031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 01)

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 01)
Chemical structure of lenalidomide, showing its molecular framework including a phthalimide ring with an amino group and a glutarimide ring.*
FDA Label Image

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 02)

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 02)
A Kaplan-Meier survival curve chart depicting progression-free survival over months for three treatment groups: Rd Continuous, Rd18, and MPT. The y-axis shows survival probability percentage, and the x-axis shows progression-free survival time in months. A table below displays the number of subjects at risk at various time points for each group.*
FDA Label Image

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 03)

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 03)
A survival probability Kaplan-Meier plot showing overall survival over time in months for three treatment groups labeled Rd Continuous, Rd18, and MPT. The graph includes survival curves for each group, hazard ratios with 95% confidence intervals, and a table indicating the number of subjects at risk at various time points.*
FDA Label Image

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 06)

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 06)
A Kaplan-Meier survival curve showing proportion of subjects over time to disease progression in months, comparing Lenalidomide/Dex and Placebo/Dex treatment groups. The plot includes a hazard ratio (HR) of 0.285 with 95% confidence interval (0.210-0.386) and a statistically significant log-rank p-value less than 0.001.*
FDA Label Image

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 07)

Image (6077738e 3c5b 49de Bb89 E9d34e166c9c 07)
A Kaplan-Meier survival curve comparing time to progression (months) for subjects receiving Lenalidomide/Dex versus Placebo/Dex. The y-axis shows the proportion of subjects, and the graph includes hazard ratio (HR) with 95% confidence interval and a log-rank p-value, illustrating longer progression-free survival with Lenalidomide/Dex.*
FDA Label Image

Label (6077738e 3c5b 49de Bb89 E9d34e166c9c 08)

Label (6077738e 3c5b 49de Bb89 E9d34e166c9c 08)
Lenalidomide Capsules 5 mg packaging label from Zydus Pharmaceuticals USA Inc. The label indicates the capsule strength as 5 mg and the package contains 28 capsules. It includes a warning about potential human birth defects and storage instructions. The label states that the product is prescription only (Rx only) and provides manufacturer and distributor information.*
FDA Label Image

Label (6077738e 3c5b 49de Bb89 E9d34e166c9c 09)

Label (6077738e 3c5b 49de Bb89 E9d34e166c9c 09)
Label for Lenalidomide Capsules 10 mg oral capsules by Zydus Pharmaceuticals USA Inc. The carton contains 28 capsules and bears a warning about potential human birth defects. Storage instructions and manufacturer details from Cadila Healthcare Ltd., India are also included.*
FDA Label Image

Label (6077738e 3c5b 49de Bb89 E9d34e166c9c 10)

Label (6077738e 3c5b 49de Bb89 E9d34e166c9c 10)
Lenalidomide Capsules 15 mg oral dosage form label by Zydus Pharmaceuticals USA Inc. This packaging label displays dosage strength of 15 mg, product name Lenalidomide, manufacturer details, storage instructions, and a warning about potential human birth defects. The package size is 21 capsules with Rx only designation.*
FDA Label Image

Label (6077738e 3c5b 49de Bb89 E9d34e166c9c 11)

Label (6077738e 3c5b 49de Bb89 E9d34e166c9c 11)
Lenalidomide Capsules 25 mg packaging label showing the brand and generic name, strength, dosage form, quantity of 21 capsules, and prescription status. The label includes storage instructions, manufacturer information (Cadila Healthcare Ltd., India), and distributor details (Zydus Pharmaceuticals USA Inc.). A warning for potential human birth defects is also displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.